Fenofibrate Improved Interstitial Fibrosis of Renal Allograft through Inhibited Epithelial-Mesenchymal Transition Induced by Oxidative Stress
Open Access
- 17 February 2019
- journal article
- research article
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2019, 1-12
Abstract
The best treatment for end-stage renal disease is renal transplantation. However, it is often difficult to maintain a renal allograft healthy for a long time following transplantation. Interstitial fibrosis and tubular atrophy (IF/TA) are significant histopathologic characteristics of a compromised renal allograft. There is no effective therapy to improve renal allograft function once IF/TA sets in. Although there are many underlying factors that can induce IF/TA, the pathogenesis of IF/TA has not been fully elucidated. It has been found that epithelial-mesenchymal transition (EMT) significantly contributes to the development of IF/TA. Oxidative stress is one of the main causes that induce EMT in renal allografts. In this study, we have used H2O2 to induce oxidative stress in renal tubular epithelial cells (NRK-52e) of rats. We also pretreated NRK-52e cells with an antioxidant (N-acetyl L-cysteine (NAC)) 1 h prior to the treatment with H2O2. Furthermore, we used fenofibrate (a peroxisome proliferator-activated receptor α agonist) to treat NRK-52e cells and a renal transplant rat model. Our results reveal that oxidative stress induces EMT in NRK-52e cells, and pretreatment with NAC can suppress EMT in these cells. Moreover, fenofibrate suppresses fibrosis by ameliorating oxidative stress-induced EMT in a rat model. Thus, fenofibrate may effectively prevent the development of fibrosis in renal allograft and improve the outcome.Keywords
Funding Information
- Natural Science Foundation of Jilin Province (20180101162JC)
This publication has 50 references indexed in Scilit:
- Clofibrate PPARα Activation Reduces Oxidative Stress and Improves Ultrastructure and Ventricular Hemodynamics in No-flow Myocardial IschemiaJournal of Cardiovascular Pharmacology, 2012
- Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol induced steatohepatitis in miceLipids in Health and Disease, 2011
- PPARα agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activityBiochemical and Biophysical Research Communications, 2010
- PPARin Obesity: Sex Difference and Estrogen InvolvementPPAR Research, 2010
- The basics of epithelial-mesenchymal transitionJournal of Clinical Investigation, 2009
- Early Epithelial Phenotypic Changes Predict Graft FibrosisJournal of the American Society of Nephrology, 2008
- Mechanisms of Disease: oxidative stress and inflammation in the pathogenesis of hypertensionNature Clinical Practice Nephrology, 2006
- Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney diseaseKidney International, 2004
- The elephant in uremia: Oxidant stress as a unifying concept of cardiovascular disease in uremiaKidney International, 2002
- Albumin is the major plasma protein target of oxidant stress in uremiaKidney International, 2001